BACKGROUND: Male breast cancer (MBC) is a rare disease with a rising incidence trend. The major risk factors related to MBC are a positive family history of breast cancer (BC) and BRCA1/2 mutations, which indicate a relevant genetic role. METHODS: In this retrospective series, we enrolled 69 male patients presenting with male breast cancer (MBC) between 01/01/1992 and 31/12/2018, and 26 high-risk not-affected men presenting between 01/01/2016 and 31/12/2018. Participants' electronic clinical records were reviewed. Patients' data reported age at diagnosis, tumor characteristics, therapeutic management, and BRCA1/2 status as well as a family history of breast, ovarian, or prostate cancer (PCa) in first-degree relatives. RESULTS: We analyzed 69 MBC patients. Median age was 64 years. The majority of tumors diagnosed were of an early TNM stage. The most frequent histological subtype was invasive ductal carcinoma (76.7%). Hormone receptors were positive in >90% of MBC cases. Nearly all patients underwent modified radical mastectomy or total mastectomy. Adjuvant endocrine therapy was delivered in 59.4%. Among MBC-affected patients, we recorded a high percentage of a positive family history of BC. Mutational analysis for the BRCA1/2 genes was performed in 17 MBC patients; 11.8% were carriers of BRCA2 pathogenic mutations. Among 26 healthy high-risk subjects included in this case series, 4 were BRCA1 mutation carriers and 9 were BRCA2 mutation carriers. DISCUSSION: We evaluated the distribution of clinicopathological characteristics in MBC subjects and assessed the frequency of mutations in the BRCA genes in affected patients and healthy high-risk subjects, with the aim of proposing a surveillance program for BC and PCa.
BACKGROUND: Male breast cancer (MBC) is a rare disease with a rising incidence trend. The major risk factors related to MBC are a positive family history of breast cancer (BC) and BRCA1/2 mutations, which indicate a relevant genetic role. METHODS: In this retrospective series, we enrolled 69 male patients presenting with male breast cancer (MBC) between 01/01/1992 and 31/12/2018, and 26 high-risk not-affected men presenting between 01/01/2016 and 31/12/2018. Participants' electronic clinical records were reviewed. Patients' data reported age at diagnosis, tumor characteristics, therapeutic management, and BRCA1/2 status as well as a family history of breast, ovarian, or prostate cancer (PCa) in first-degree relatives. RESULTS: We analyzed 69 MBC patients. Median age was 64 years. The majority of tumors diagnosed were of an early TNM stage. The most frequent histological subtype was invasive ductal carcinoma (76.7%). Hormone receptors were positive in >90% of MBC cases. Nearly all patients underwent modified radical mastectomy or total mastectomy. Adjuvant endocrine therapy was delivered in 59.4%. Among MBC-affected patients, we recorded a high percentage of a positive family history of BC. Mutational analysis for the BRCA1/2 genes was performed in 17 MBC patients; 11.8% were carriers of BRCA2 pathogenic mutations. Among 26 healthy high-risk subjects included in this case series, 4 were BRCA1 mutation carriers and 9 were BRCA2 mutation carriers. DISCUSSION: We evaluated the distribution of clinicopathological characteristics in MBC subjects and assessed the frequency of mutations in the BRCA genes in affected patients and healthy high-risk subjects, with the aim of proposing a surveillance program for BC and PCa.
Authors: E Senkus; S Kyriakides; S Ohno; F Penault-Llorca; P Poortmans; E Rutgers; S Zackrisson; F Cardoso Journal: Ann Oncol Date: 2015-09 Impact factor: 32.976
Authors: Larissa A Korde; Jo Anne Zujewski; Leah Kamin; Sharon Giordano; Susan Domchek; William F Anderson; John M S Bartlett; Karen Gelmon; Zeina Nahleh; Jonas Bergh; Bruno Cutuli; Giancarlo Pruneri; Worta McCaskill-Stevens; Julie Gralow; Gabriel Hortobagyi; Fatima Cardoso Journal: J Clin Oncol Date: 2010-03-22 Impact factor: 44.544
Authors: Z Kote-Jarai; D Leongamornlert; E Saunders; M Tymrakiewicz; E Castro; N Mahmud; M Guy; S Edwards; L O'Brien; E Sawyer; A Hall; R Wilkinson; T Dadaev; C Goh; D Easton; D Goldgar; R Eeles Journal: Br J Cancer Date: 2011-09-27 Impact factor: 7.640
Authors: Elizabeth K Bancroft; Elizabeth C Page; Elena Castro; Hans Lilja; Andrew Vickers; Daniel Sjoberg; Melissa Assel; Christopher S Foster; Gillian Mitchell; Kate Drew; Lovise Mæhle; Karol Axcrona; D Gareth Evans; Barbara Bulman; Diana Eccles; Donna McBride; Christi van Asperen; Hans Vasen; Lambertus A Kiemeney; Janneke Ringelberg; Cezary Cybulski; Dominika Wokolorczyk; Christina Selkirk; Peter J Hulick; Anders Bojesen; Anne-Bine Skytte; Jimmy Lam; Louise Taylor; Rogier Oldenburg; Ruben Cremers; Gerald Verhaegh; Wendy A van Zelst-Stams; Jan C Oosterwijk; Ignacio Blanco; Monica Salinas; Jackie Cook; Derek J Rosario; Saundra Buys; Tom Conner; Margreet G Ausems; Kai-ren Ong; Jonathan Hoffman; Susan Domchek; Jacquelyn Powers; Manuel R Teixeira; Sofia Maia; William D Foulkes; Nassim Taherian; Marielle Ruijs; Apollonia T Helderman-van den Enden; Louise Izatt; Rosemarie Davidson; Muriel A Adank; Lisa Walker; Rita Schmutzler; Kathy Tucker; Judy Kirk; Shirley Hodgson; Marion Harris; Fiona Douglas; Geoffrey J Lindeman; Janez Zgajnar; Marc Tischkowitz; Virginia E Clowes; Rachel Susman; Teresa Ramón y Cajal; Nicholas Patcher; Neus Gadea; Allan Spigelman; Theo van Os; Annelie Liljegren; Lucy Side; Carole Brewer; Angela F Brady; Alan Donaldson; Vigdis Stefansdottir; Eitan Friedman; Rakefet Chen-Shtoyerman; David J Amor; Lucia Copakova; Julian Barwell; Veda N Giri; Vedang Murthy; Nicola Nicolai; Soo-Hwang Teo; Lynn Greenhalgh; Sara Strom; Alex Henderson; John McGrath; David Gallagher; Neil Aaronson; Audrey Ardern-Jones; Chris Bangma; David Dearnaley; Philandra Costello; Jorunn Eyfjord; Jeanette Rothwell; Alison Falconer; Henrik Gronberg; Freddie C Hamdy; Oskar Johannsson; Vincent Khoo; Zsofia Kote-Jarai; Jan Lubinski; Ulrika Axcrona; Jane Melia; Joanne McKinley; Anita V Mitra; Clare Moynihan; Gad Rennert; Mohnish Suri; Penny Wilson; Emma Killick; Sue Moss; Rosalind A Eeles Journal: Eur Urol Date: 2014-01-15 Impact factor: 20.096
Authors: Valentina Silvestri; Daniel Barrowdale; Anna Marie Mulligan; Susan L Neuhausen; Stephen Fox; Beth Y Karlan; Gillian Mitchell; Paul James; Darcy L Thull; Kristin K Zorn; Natalie J Carter; Katherine L Nathanson; Susan M Domchek; Timothy R Rebbeck; Susan J Ramus; Robert L Nussbaum; Olufunmilayo I Olopade; Johanna Rantala; Sook-Yee Yoon; Maria A Caligo; Laura Spugnesi; Anders Bojesen; Inge Sokilde Pedersen; Mads Thomassen; Uffe Birk Jensen; Amanda Ewart Toland; Leigha Senter; Irene L Andrulis; Gord Glendon; Peter J Hulick; Evgeny N Imyanitov; Mark H Greene; Phuong L Mai; Christian F Singer; Christine Rappaport-Fuerhauser; Gero Kramer; Joseph Vijai; Kenneth Offit; Mark Robson; Anne Lincoln; Lauren Jacobs; Eva Machackova; Lenka Foretova; Marie Navratilova; Petra Vasickova; Fergus J Couch; Emily Hallberg; Kathryn J Ruddy; Priyanka Sharma; Sung-Won Kim; Manuel R Teixeira; Pedro Pinto; Marco Montagna; Laura Matricardi; Adalgeir Arason; Oskar Th Johannsson; Rosa B Barkardottir; Anna Jakubowska; Jan Lubinski; Angel Izquierdo; Miguel Angel Pujana; Judith Balmaña; Orland Diez; Gabriella Ivady; Janos Papp; Edith Olah; Ava Kwong; Heli Nevanlinna; Kristiina Aittomäki; Pedro Perez Segura; Trinidad Caldes; Tom Van Maerken; Bruce Poppe; Kathleen B M Claes; Claudine Isaacs; Camille Elan; Christine Lasset; Dominique Stoppa-Lyonnet; Laure Barjhoux; Muriel Belotti; Alfons Meindl; Andrea Gehrig; Christian Sutter; Christoph Engel; Dieter Niederacher; Doris Steinemann; Eric Hahnen; Karin Kast; Norbert Arnold; Raymonda Varon-Mateeva; Dorothea Wand; Andrew K Godwin; D Gareth Evans; Debra Frost; Jo Perkins; Julian Adlard; Louise Izatt; Radka Platte; Ros Eeles; Steve Ellis; Ute Hamann; Judy Garber; Florentia Fostira; George Fountzilas; Barbara Pasini; Giuseppe Giannini; Piera Rizzolo; Antonio Russo; Laura Cortesi; Laura Papi; Liliana Varesco; Domenico Palli; Ines Zanna; Antonella Savarese; Paolo Radice; Siranoush Manoukian; Bernard Peissel; Monica Barile; Bernardo Bonanni; Alessandra Viel; Valeria Pensotti; Stefania Tommasi; Paolo Peterlongo; Jeffrey N Weitzel; Ana Osorio; Javier Benitez; Lesley McGuffog; Sue Healey; Anne-Marie Gerdes; Bent Ejlertsen; Thomas V O Hansen; Linda Steele; Yuan Chun Ding; Nadine Tung; Ramunas Janavicius; David E Goldgar; Saundra S Buys; Mary B Daly; Anita Bane; Mary Beth Terry; Esther M John; Melissa Southey; Douglas F Easton; Georgia Chenevix-Trench; Antonis C Antoniou; Laura Ottini Journal: Breast Cancer Res Date: 2016-02-09 Impact factor: 6.466
Authors: Hannah R Brewer; Michael E Jones; Minouk J Schoemaker; Alan Ashworth; Anthony J Swerdlow Journal: Breast Cancer Res Treat Date: 2017-06-03 Impact factor: 4.872
Authors: Jennifer K Plichta; Yi Ren; Caitlin E Marks; Samantha M Thomas; Rachel A Greenup; Laura H Rosenberger; Oluwadamilola M Fayanju; Susan G R McDuff; E Shelley Hwang; Jeremy Force Journal: Ann Surg Oncol Date: 2020-07-23 Impact factor: 5.344